BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4794218)

  • 1. [Antivitamin K agents].
    Nicolas G
    Rev Prat; 1973 Dec; 23(60):5393-400. PubMed ID: 4794218
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vitamin K antagonists].
    Chabalier R; Lévy G
    Ann Anesthesiol Fr; 1978; 19(10):IN-5N. PubMed ID: 35048
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory control of the effect of anti-vitamins K on blood coagulation].
    Langer B; Muraco B; Manasterski J; Bechara MJ; Sitrângulo Júnior C; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):12-7. PubMed ID: 6484435
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of SKF 525A on the kinetics and action of an antivitamin K in the rat].
    Thonnart N; Letist D; Reuse J
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):369-72. PubMed ID: 4848952
    [No Abstract]   [Full Text] [Related]  

  • 5. [Duration of antivitamin K treatment in venous thromboembolic disease].
    Pinede L; Ninet J
    Arch Mal Coeur Vaiss; 1996 Jul; 89(7):927-31. PubMed ID: 8869257
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of a new antivitamin K: 6134 M.D. 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol].
    Pernod J; Kermarec J; Migne J
    Therapie; 1968; 23(3):567-74. PubMed ID: 4906093
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and laboratory evaluation of patients treated with oral anticoagulation].
    Lourenço DM; Lopes LH; Vignal CV; Morelli VM
    Arq Bras Cardiol; 1997 May; 68(5):353-6. PubMed ID: 9497524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Duration of antivitamin K therapy in venous thromboembolic disease].
    Ferrari E; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel anticoagulants and the future of anticoagulation.
    Garcia D
    Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 13. Travel and oral anticoagulation.
    Ringwald J; Strobel J; Eckstein R
    J Travel Med; 2009; 16(4):276-83. PubMed ID: 19674269
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of deep venous thrombosis with low-molecular-weight heparin].
    Samama MM; Achkar A; Horellou MH
    Rev Med Brux; 1995; 16(4):304-9. PubMed ID: 7481248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New anticoagulants: an update.
    Crowther M; Weitz JI
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):743-9. PubMed ID: 16170892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The adult intensive care physician and antivitamin K agents].
    Auzépy P; Rimailho A; Souied G; Riou B
    Agressologie; 1983 Nov; 24(11):549-54. PubMed ID: 6367510
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K].
    Langer B; Fuess VL; Kauffman P; Bechara MJ; dos Reis JM; Kwang WT
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):18-22. PubMed ID: 6385200
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical pharmacology of drugs used in thromboembolism].
    Orzechowska-Juzwenko K
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1663-7. PubMed ID: 6679090
    [No Abstract]   [Full Text] [Related]  

  • 19. High usual dietary vitamin K intake is associated with low relative variability in vitamin K intake: implications for anticoagulant therapy.
    Presse N; Kergoat MJ; Ferland G
    Br J Haematol; 2011 Apr; 153(1):129-30. PubMed ID: 21275964
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitamin K and oral anticoagulation: thought for food.
    Bovill EG; Fung M; Cushman M
    Am J Med; 2004 May; 116(10):711-3. PubMed ID: 15121498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.